KR20160130780A - Methods for diagnosing and treating inflammatory

Official gazette of the unexamined patents

Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study

Technology Insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial - The Lancet Gastroenterology & Hepatology

Serum Inflammatory Mediators as Markers of Human Lyme Disease Activity

The Clinical Response of Upadacitinib and Risankizumab is Associated with Reduced Inflammatory Bowel Disease Anti-TNFα Inadequate Response Mechanisms

Technology Insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies

xmlinkhub

Technology Insight: tools for research, diagnosis and clinical assessment of treatment in idiopathic inflammatory myopathies

Serum Inflammatory Mediators as Markers of Human Lyme Disease Activity

Inflammatory bowel disease biomarkers - Liu - 2022 - Medicinal Research Reviews - Wiley Online Library